DK157880C - Analogifremgangsmaade til fremstilling af corticoid-21-halogen-17-alkylcarbonater - Google Patents

Analogifremgangsmaade til fremstilling af corticoid-21-halogen-17-alkylcarbonater

Info

Publication number
DK157880C
DK157880C DK168579A DK168579A DK157880C DK 157880 C DK157880 C DK 157880C DK 168579 A DK168579 A DK 168579A DK 168579 A DK168579 A DK 168579A DK 157880 C DK157880 C DK 157880C
Authority
DK
Denmark
Prior art keywords
corticoid
halogen
preparing
alkyl carbonate
analogy procedure
Prior art date
Application number
DK168579A
Other languages
English (en)
Other versions
DK157880B (da
DK168579A (da
Inventor
Ulrich Stache
Werner Fritsch
Hans Georg Alpermann
Juergen Kurt Sandow
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK168579A publication Critical patent/DK168579A/da
Publication of DK157880B publication Critical patent/DK157880B/da
Application granted granted Critical
Publication of DK157880C publication Critical patent/DK157880C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK168579A 1978-04-25 1979-04-24 Analogifremgangsmaade til fremstilling af corticoid-21-halogen-17-alkylcarbonater DK157880C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19782817988 DE2817988A1 (de) 1978-04-25 1978-04-25 Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
DE2817988 1978-04-25

Publications (3)

Publication Number Publication Date
DK168579A DK168579A (da) 1979-10-26
DK157880B DK157880B (da) 1990-02-26
DK157880C true DK157880C (da) 1990-07-30

Family

ID=6037909

Family Applications (1)

Application Number Title Priority Date Filing Date
DK168579A DK157880C (da) 1978-04-25 1979-04-24 Analogifremgangsmaade til fremstilling af corticoid-21-halogen-17-alkylcarbonater

Country Status (19)

Country Link
US (1) US4377575A (da)
EP (1) EP0004975B1 (da)
JP (1) JPS54144357A (da)
AR (1) AR226157A1 (da)
AT (1) AT372094B (da)
AU (1) AU529172B2 (da)
CA (1) CA1130276A (da)
DE (2) DE2817988A1 (da)
DK (1) DK157880C (da)
ES (2) ES479709A1 (da)
FI (1) FI791307A (da)
GR (1) GR72886B (da)
HU (1) HU180788B (da)
IE (1) IE48328B1 (da)
IL (1) IL57114A (da)
NO (1) NO791365L (da)
NZ (1) NZ190256A (da)
PT (1) PT69544A (da)
ZA (1) ZA791941B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
JPS5835199A (ja) * 1981-08-26 1983-03-01 Mitsubishi Chem Ind Ltd モノヨ−ドステロイドおよびその製造法
JPS58103400A (ja) * 1981-12-11 1983-06-20 Ota Seiyaku Kk ６α−メチルプレドニゾロン誘導体
AU558725B2 (en) * 1983-09-07 1987-02-05 Mitsubishi Kasei Corporation Corticoid derivatives
JPS6056997A (ja) * 1983-09-07 1985-04-02 Mitsubishi Chem Ind Ltd 新規な６−酸素化コルチコイド／７α−カ−ボネ−ト誘導体およびその製法
DE4025342A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE4328819A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Corticosteroid-17-alkylcarbonat-21/0/-Carbonsäure- und Kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4333920A1 (de) 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
PT2348032E (pt) * 2000-08-05 2015-10-14 Glaxo Group Ltd Éster s-fluorometílico do ácido 6.alfa.,9.alfa.-difluoro- 17.alfa.-'(2-furanilcarboxil)oxi]-11.beta.-hidroxi-16.alfa.- metil-3-oxo-androsta-1,4-dieno-17-carbotióico como um agente anti-inflamatório
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
CA2445839A1 (en) * 2001-04-30 2002-11-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
KR20100087147A (ko) * 2007-10-04 2010-08-03 아스트라제네카 아베 글루코코르티코이드 활성을 갖는 스테로이드성 [3,2-ｃ]피라졸 화합물
JP2011507836A (ja) * 2007-12-20 2011-03-10 アストラゼネカ・アクチエボラーグ グルココルチコステロイド受容体アゴニストとして作用するステロイド誘導体
UY32520A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
UY32525A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32523A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32521A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Combinación para emplear en el tratamiento de enfermedades respiratorias

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1253831A (en) * 1968-01-19 1971-11-17 Glaxo Lab Ltd 9alpha,21-DIHALOPREGNANE COMPOUNDS
GB1281689A (en) * 1968-10-14 1972-07-12 Glaxo Lab Ltd Steroid 21-phosphates
US3558675A (en) * 1969-06-30 1971-01-26 Merck & Co Inc Steroid carbonates and process
GB1440063A (en) * 1972-08-11 1976-06-23 Glaxo Lab Ltd 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids
US3832366A (en) * 1973-07-30 1974-08-27 Squibb & Sons Inc Process for preparing 21-chloro-17-acyloxy-20-ketosteroids
YU54476A (en) * 1975-03-31 1982-05-31 Taisho Pharmaceutical Co Ltd Process for obtaining 17-ester 21-halo-pregnane
US4021459A (en) * 1975-08-14 1977-05-03 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy 20-keto-pregnenes
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
NO791365L (no) 1979-10-26
GR72886B (da) 1984-01-02
EP0004975A2 (de) 1979-10-31
ES479709A1 (es) 1980-08-16
PT69544A (de) 1979-05-01
EP0004975A3 (en) 1979-11-14
IE48328B1 (en) 1984-12-12
EP0004975B1 (de) 1982-02-17
ATA307479A (de) 1983-01-15
US4377575A (en) 1983-03-22
AT372094B (de) 1983-08-25
DE2817988A1 (de) 1979-11-08
NZ190256A (en) 1981-03-16
IL57114A0 (en) 1979-07-25
DK157880B (da) 1990-02-26
DE2962122D1 (en) 1982-03-25
ZA791941B (en) 1980-04-30
JPS6252759B2 (da) 1987-11-06
IL57114A (en) 1983-11-30
AU529172B2 (en) 1983-05-26
FI791307A (fi) 1979-10-26
CA1130276A (en) 1982-08-24
ES488120A1 (es) 1980-09-16
JPS54144357A (en) 1979-11-10
HU180788B (en) 1983-04-29
DK168579A (da) 1979-10-26
IE790831L (en) 1979-10-25
AR226157A1 (es) 1982-06-15

Similar Documents

Publication Publication Date Title
DK157880C (da) Analogifremgangsmaade til fremstilling af corticoid-21-halogen-17-alkylcarbonater
DK149023C (da) Analogifremgangsmaade til fremstilling af tiazolidinderivater
DK153552C (da) Analogifremgangsmaade til fremstilling af 1,8-naphthyridinderivater
DK425579A (da) Fremgangsmaade til fremstilling af heterocycliske forbindelser
DK149749C (da) Analogifremgangsmaade til fremstilling af n-alkyl-2-hydroxy-metyl-3,4,5-trihydroxy-piperidinderivater
DK7579A (da) Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid
DK54879A (da) Fremgangsmaade til fremstilling af pyrimidoner
DK19579A (da) Fremgangsmaade til fremstilling af spirothienohydantoinderivater
DK151252C (da) Analogifremgangsmaade til fremstilling af 3-alkyltio-4-oxoquinolinforbindelser
DK153844C (da) Analogifremgangsmaade til fremstilling af 1,2,3,5-tetrahydroimidazothienopyrimidin-2-oner
DK145698C (da) Analogifremgangsmaade til fremstilling af 2-alkoxyadeninderivater
DK148059C (da) Analogifremgangsmaade til fremstilling af anthracyclinglycosidforbindelser
DK147145C (da) Analogifremgangsmaade til fremstilling af chlorambucilderivater
DK311779A (da) Fremgangsmaade til fremstilling af spaanplader
DK153379A (da) Fremgangsmaade til fremstilling af n,n,n!,n!-tetraacetylethylendiamin
DK138879A (da) Fremgangsmaade til fremstilling af lysergolderivater
DK161198C (da) Analogifremgangsmaade til fremstilling af substituerede omega-aroylpropionyl-l-proliner
DK154136C (da) Analogifremgangsmaade til fremstilling af 2-amino-3-benzoylphenylacetamider
DK330279A (da) Fremgangsmaade til fremstilling af soem
DK41079A (da) Fremgangsmaade til masselimning af papir
DK150147C (da) Analogifremgangsmaade til fremstilling af forbindelser af muramyldipeptidtypen
DK142848C (da) Analogifremgangsmaade til fremstilling af 2-acylamido-4-amino-5-benzylpyrimidinforbindelser
DK153838C (da) Analogifremgangsmaade til fremstilling af 2,4-dichlor-alfa-(n-imidazolylmethyl)-dibenzylethere
DK127179A (da) Fremgangsmaade til fremstilling af monokaryoner
DK40479A (da) Fremgangsmaade til fremstilling af monorden

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed
PBP Patent lapsed